Chargement en cours...
Should Low Molecular Weight PSMA Targeted Ligands Get Bigger and Use Albumin Ligands for PSMA Targeting?
Prostate Specific Membrane Antigen (PSMA) is strongly expressed in prostate cancer. Recently a number of low-molecular-weight inhibitors have demonstrated excellent PSMA targeting activity for both imaging as well as Lutecium-177 radiotherapy in human trials. The paper by Choy et al raises the quest...
Enregistré dans:
| Publié dans: | Theranostics |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Ivyspring International Publisher
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5479280/ https://ncbi.nlm.nih.gov/pubmed/28638479 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.20284 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|